Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2003, Vol. 8 ›› Issue (5): 582-584.

Previous Articles     Next Articles

Evaluation of efficacy and safety of rifamycin sodium injection in treat-ment ofPatients withPulmonary tuberculosis

JIN Yi-Feng, ZHANG Xia-Zhi, XIE Jia-Zhen, TU Xiong-Wen   

  1. Department of Respiratory Medicine,Yijishan Hospital,Wannan Medical College,Wuhu 241001,Anhui,China
  • Received:2003-03-24 Revised:2003-04-17 Online:2003-10-26 Published:2020-11-19

Abstract: AIM: To evaluate the therapeutic effect and safety of the rifamycin sodium injection (SV)in treatment ofPatients withPulmonary tuberculosis.METHODS: 44 cases ofPulmonary tuberculosis were randomly allocated to two groups:rifamycin sodium grouPand routine treatment group.Chemotherapy regimens:in the rifamycin sodium group,21 cases were treated with the regimen of 2HZE +SV/7HR;and in the routine treat-ment group,23 cases were treated with the regimen of 2HRZE/7HR.RESULTS: The sputum negative conver-sion rate of the rifamycin sodium grouPwas 85.7%,and the foci vanishing rate was 90.5%,while the both rates in the routine treatment grouPwere 60.9%and 60.9%,respectively.There was significant difference between the two groups (P<0.05).CONCLUSION: The therapeu-tic regimen with SV is effective in the sputum negative conversion and vanishing of foci.

Key words: pharmacodynamics, rifamycin sodium injection, rifampin, pulmonary tuberculosis

CLC Number: